Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells

<p>Abstract</p> <p>Background</p> <p>Inability to control autoimmunity is the primary barrier to developing a cure for type 1 diabetes (T1D). Evidence that human cord blood-derived multipotent stem cells (CB-SCs) can control autoimmune responses by altering regulatory T...

Full description

Bibliographic Details
Main Authors: Zhao Yong, Jiang Zhaoshun, Zhao Tingbao, Ye Mingliang, Hu Chengjin, Yin Zhaohui, Li Heng, Zhang Ye, Diao Yalin, Li Yunxiang, Chen Yingjian, Sun Xiaoming, Fisk Mary, Skidgel Randal, Holterman Mark, Prabhakar Bellur, Mazzone Theodore
Format: Article
Language:English
Published: BMC 2012-01-01
Series:BMC Medicine
Online Access:http://www.biomedcentral.com/1741-7015/10/3